TA

TAO Synergies Inc.

TAOX · Nasdaq

TAO Synergies Inc. (TAOX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for TAO Synergies Inc. in 2026. The next earnings report is expected on December 2, 2026.

Earnings calendar

Next earnings date

02 Dec 2026

In 102 days

EPS estimate

-2.06

Revenue estimate

Past earnings

13 Aug 2026
EPS actual
estimate -2.06
Revenue actual
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
27 Mar 2025
EPS actual
estimate -2.06
Revenue actual
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Joshua N. Silverman
Employees
4
IPO date
02 Jul 2025
ISIN
US87167T3005
Website
synaptogen.com

Frequently asked questions

When does TAO Synergies Inc. (TAOX) next report earnings?

TAO Synergies Inc. (TAOX) is scheduled to report earnings on December 2, 2026.

What was TAO Synergies Inc.'s most recent earnings date?

TAO Synergies Inc. (TAOX) last reported earnings on August 13, 2026.

Where is TAO Synergies Inc. stock listed?

TAO Synergies Inc. (TAOX) is listed on Nasdaq.